This article was originally on a blog post platform and may be missing photos, graphics or links.

Women who received the HPV vaccine after surgical excision for high-grade cervical dysplasia had lower risk for recurrence than women who received placebo or surgery alone, according to results of ...

The precise cause of cervical dysplasia is not known, but it has been linked to exposure to certain strains of the human papillomavirus (HPV). HPV is a group of more than 100 viruses.

Although cervical dysplasia is not cancer, it is a precancerous condition, which means it may develop into cancer if left untreated. Cervical dysplasia is also known as cervical intraepithelial ...

Cervical cancer begins as noninvasive dysplasia, which is the presence of cells in the cervix that are abnormal but not cancerous. The Pap test examines a sample of cells from the cervix for ...

Although cervical dysplasia is not cancer, it is a precancerous condition, which means it may develop into cancer if left untreated. Cervical dysplasia is also known as cervical intraepithelial ...

These results suggest that rAd5 vaccines delivered to a mucosal surface may have therapeutic potential in the treatment of HPV-derived cervical dysplasia and might be used to stimulate immune ...

Early discovery and treatment of cervical dysplasia can prevent more serious problems later. Many kinds of providers can do a pap smear, including: primary care doctors, ... An HPV test result can be ...

HPV: HPV is a common infection, and some types of the virus have significant links to various cancers, including cervical cancer. There is no cure for HPV, ... called cervical dysplasia.

- Data show that Vaxart’s HPV vaccine constructs stimulate specific T cell immune responses, reduce tumor size, and increase survival in an animal model of human papillomavirus (HPV)-related ...

INOVIO's lead immunotherapy candidate, VGX-3100, currently in Phase 3 trials for precancerous cervical dysplasia, cleared high-risk HPV-16 and/or HPV-18 in a Phase 2b clinical trial.